GB201721718D0 - Treatment of cystic fibrosis - Google Patents

Treatment of cystic fibrosis

Info

Publication number
GB201721718D0
GB201721718D0 GBGB1721718.3A GB201721718A GB201721718D0 GB 201721718 D0 GB201721718 D0 GB 201721718D0 GB 201721718 A GB201721718 A GB 201721718A GB 201721718 D0 GB201721718 D0 GB 201721718D0
Authority
GB
United Kingdom
Prior art keywords
treatment
cystic fibrosis
cystic
fibrosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1721718.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BenevolentAI Bio Ltd
Original Assignee
BenevolentAI Bio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BenevolentAI Bio Ltd filed Critical BenevolentAI Bio Ltd
Priority to GBGB1721718.3A priority Critical patent/GB201721718D0/en
Publication of GB201721718D0 publication Critical patent/GB201721718D0/en
Priority to PCT/GB2018/053734 priority patent/WO2019122911A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB1721718.3A 2017-12-22 2017-12-22 Treatment of cystic fibrosis Ceased GB201721718D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1721718.3A GB201721718D0 (en) 2017-12-22 2017-12-22 Treatment of cystic fibrosis
PCT/GB2018/053734 WO2019122911A1 (en) 2017-12-22 2018-12-21 Tranilast for cystic fibrosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1721718.3A GB201721718D0 (en) 2017-12-22 2017-12-22 Treatment of cystic fibrosis

Publications (1)

Publication Number Publication Date
GB201721718D0 true GB201721718D0 (en) 2018-02-07

Family

ID=61131496

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1721718.3A Ceased GB201721718D0 (en) 2017-12-22 2017-12-22 Treatment of cystic fibrosis

Country Status (2)

Country Link
GB (1) GB201721718D0 (en)
WO (1) WO2019122911A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008247789A (en) * 2007-03-30 2008-10-16 Kissei Pharmaceut Co Ltd Medicinal composition for suppressing progress of constriction of intestinal tract accompanied by crohn disease
CN101375843B (en) * 2007-08-29 2011-12-28 上海新康制药厂 Compound tranilast orally disintegrating tablet formulation and preparation method thereof
CN101152163B (en) * 2007-09-14 2010-05-26 李世荣 Anti-cicatrix externally used pad pasting containing hormone medicament and method for preparing the same
US20110288134A1 (en) * 2008-10-29 2011-11-24 Pacific Therapeutics Ltd. Composition and method for treating fibrosis
WO2010071866A2 (en) * 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Combination therapy for arthritis with tranilast
CN104208699A (en) * 2013-05-29 2014-12-17 天津金耀集团有限公司 Compound oral preparation containing antibacterial drugs
CN106361737A (en) * 2016-09-06 2017-02-01 南京医科大学第附属医院 Application of tranilast in preparation of medicament for treating tuberculosis

Also Published As

Publication number Publication date
WO2019122911A1 (en) 2019-06-27

Similar Documents

Publication Publication Date Title
IL272032A (en) Methods of treatment for cystic fibrosis
IL271181A (en) Methods of treatment for cystic fibrosis
HRP20181692T1 (en) Treatment of fibrosis
HK1258396A1 (en) Cenicriviroc combination therapy for the treatment of fibrosis
ZA202006746B (en) Methods of treatment
IL282988A (en) Methods of treatment for cystic fibrosis
IL250960A0 (en) Cenicriviroc combination therapy for the treatment of fibrosis
HK1232147A1 (en) Cenicriviroc for the treatment of fibrosis
EP3204007C0 (en) Triazolopyridine compounds and methods for the treatment of cystic fibrosis
IL266530A (en) Treatment for fibrosis
IL280343A (en) Treatment of mucopolysaccharidosis iva
HK1247558A1 (en) Cenicriviroc for the treatment of fibrosis
EP3596067C0 (en) Pyrazole derivatives for the treatment of cystic fibrosis
SG11202005850VA (en) Methods of treatment of hypertrigl yceridemia
GB201721718D0 (en) Treatment of cystic fibrosis
HK1246718A1 (en) Compounds for treatment of cystic fibrosis
EP3727359C0 (en) Treatment of fibrosis with inositol
HK1258824A1 (en) Chair-type massager
GB201713042D0 (en) Contra rotating massager
GB201507371D0 (en) Prediction and treatment of progressive fibrosis
GB201407806D0 (en) Treatment of fibrosis
AU2014904206A0 (en) Treatment of fibrosis
GB201403630D0 (en) Treatment of cystic fibrosis with alginate oligomers
GB201409159D0 (en) Prediction and treatment of progressive fibrosis

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)